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Bullous pemphigoid (BP) has a recognized association with 
solid organ tumors, but is relatively rare in hematological 
malignancies. We report a 67-year-old male who developed 
BP after being diagnosed with myelodysplastic syndrome  
and refractory anemia with excess of blast (RAEB). Skin 
biopsy elucidated sub-epidermal bulla using direct im-
munofluorescence, revealing linear C3 and IgG deposits 
along the basement membrane. His BP was recalcitrant to 
the conventional treatment and only responded to a 
combination of high dose oral prednisolone and azath-
ioprine. The relative refractory nature of his condition and 
concurrent RAEB supports a paraneoplastic nature. (Ann 
Dermatol 23(S3) S390∼S392, 2011)
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INTRODUCTION
Bullous pemphigoid (BP) has a well-recognized associ-
ation with malignancies though concrete evidence of its 
correlation remain uncertain
1,2. We report our experience 
of a male patient with a diagnosis of myelodysplastic 
syndrome (MDS) and refractory anemia with excess of 
blast (RAEB), that presented with extensive bullous erup-
tion. We believe this to be a rare case of RAEB presenting 
with paraneoplastic BP.
CASE REPORT
A 67-year-old Chinese male presented to our department 
with exquisitely pruritic bullae eruption about 3 months 
after being diagnosed with MDS with RAEB. The diagnosis 
was based on his bone marrow aspiration and trephine 
biopsy, which showed dysplastic features of all three cell 
lines with blast cells constituting 17% of the nucleated 
cells in the marrow. He also had a background history of 
multiple illnesses such as hypertension, ischemic heart 
disease, bronchial asthma and atrophic gastritis. His 
treatment for MDS with RAEB remained supportive with 
regular monthly blood transfusions as he had refused the 
option of chemotherapy due to his co-morbidities. The 
bullae started on this trunk and limbs, and later progressed 
to involve his mucous membrane. There was no history of 
new medications, supplements or other traditional medi-
cations intake within the last year.
Clinically, the patient had extensive tense, hemorrhagic 
bullae on erythematous plaques on his limbs, with pre-
dominance over the acral regions (Fig. 1), and Nikolsky’s 
sign was negative. In addition, there were multiple bullae 
on his oral mucosa, but the lesions spared his genitalia 
and eyes. Skin biopsy showed a sub-epidermal bulla with 
mild perivascular and periappendageal lymphocytic 
infiltration and a sprinkling of eosinophils (Fig. 2). Direct 
immunofluorescence revealed linear C3 and IgG deposits Paraneoplastic Bullous Pemphigoid
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Fig. 1. Multiple hemorrhagic tense bullae on erythematous and normal skin with scattered dried erosions (hand and foot). 
Fig. 2. Presence of subepidermal bullae with surrounding periva-
scular and periadnexal lymphocytic inflammation (H&E, ×4).
along the basement membrane and these confirmed the 
diagnosis of BP. His cutaneous condition was not 
controlled with oral prednisolone at 30 mg daily (0.5 mg 
/kg/day). The bullous eruptions were finally contained 
with a combination of oral prednisolone at 30 mg daily 
and azathioprine at 100 mg daily.
DISCUSSION
MDS is a heterogeneous group of malignant hemato-
poietic stem cell disorders which include six well-defined 
clinical entities: refractory anemia (RA), RA with multi-
lineage dysplasia, RA with ringed sideroblasts, RAEB, 
MDS, unclassifiable and MDS association with del(5q)
3. 
Cutaneous manifestations are rare in MDS with reports of 
Sweet's syndrome and myeloid sarcoma being the two 
most common, usually heralding the transformation to 
acute leukemia. BP is an acquired blistering dermatosis 
characterized by an autoimmune response to two hemi-
desmosomal proteins within the dermal-epidermal junc-
tion, specifically BP180 and BP230, leading to the 
production of IgG auto antibodies
4. Although BP has been 
reported to be associated with malignancy, concrete 
evidence of its correlation and paraneoplastic significance 
remain uncertain
1,2. Chorzelski et al. reported 11% of his 
BP patients to have an underlying neoplasia which was 
consistent with other reports
2,5. However, this association 
is not unexpected as both of these diseases are more 
common among the elderly. Venning and Wojnarowska 
suggested that the relationship between neoplasia and BP 
could be due to the production of antibodies to 
tumor-specific antigens that may cross-react with the 
basement membrane zone (BMZ) leading to the develop-
ment of bullae
6. Other theories postulated the role of an 
external agent generating both the tumor and the BMZ 
damage, or the possibility of genetic predisposition to 
both conditions
7. Bauduer et al. also described a case of 
BP as a paraneoplastic manifestation in an elderly lady 
who presented with synchronism between BP and trans-
formation of a pre-existing MDS
8. Our patient developed 
BP shortly after diagnosis of MDS with RAEB. This 
remarkable coincidence was reported by Modiano et al. 
who postulated that the tumor infiltrate could have 
produced antigenic determinants leading to the develop-
ment of BP
9. The typical distribution of BP on flexural skin 
areas with infrequent oral involvement is in contrast to our 
patient who presented with bullae and erosions predo-
minantly in his distal extremities and oral cavity. This 
again suggested a more severe form of disease, occurring 
in association with RAEB.
The management of patients with BP is largely dependent YY Lee, et al
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on the degree of cutaneous involvement and rate of di-
sease progression. This condition is generally quite res-
ponsive to oral steroid therapy, with up to 75% of patients 
achieving prolonged clinical remission without further 
therapy
2,10. Patients with localized disease may sometimes 
be managed successfully with potent topical steroids
2,11. 
Those with moderate diseases are often treated with oral 
prednisolone. Steroid sparing agents are only added for 
patients with extensive disease that are not responding 
well to prednisolone monotherapy. Our patient, who had 
severe disease, required two systemic agents to arrest his 
cutaneous eruption. This is in parallel with the nature of 
paraneoplastic disease, whereby the progression of his 
cutaneous lesions follows that of his MDS and RAEB. 
Hence, with the absence of treatment for the latter, his BP 
was more recalcitrant to treatment. 
In summary, the simultaneous occurrence of BP in the 
presence of MDS with RAEB suggests that BP may be a 
rare paraneoplastic syndrome, although this association 
has yet to be defined.
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